Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics

Yongwhan Choi, Seungho Lim, Hong Yeol Yoon, Byung Soo Kim, Ick Chan Kwon, Kwang Meyung Kim

Research output: Contribution to journalReview article

Abstract

Introduction: In the past decade, the glycol chitosan nanocarriers (GCNCs) have been widely used for tumor-targeted delivery of anticancer agents such as chemo drugs, peptides, and genes due to their biocompatibility, biodegradability, and easy fabrication. In particular, GCNCs can effectively solubilize water-insoluble chemo drugs as well as improve the delivery efficiency of chemo drugs to the tumor, resulting in maximizing therapeutic efficacy and minimizing side effect. In this review, we introduce the various applications of GCNCs for cancer treatment and these GCNCs demonstrate the great potential in overcoming challenges of chemotherapeutics. Areas covered: Various designs of GC nanocarriers have been reviewed. The current state of GC nanocarriers for delivering chemotherapeutics with a focus on their physicochemical properties including solubilization of anti-cancer drugs, sustained release, and tumor-selectivity. Furthermore, state of the art in delivery and therapeutic strategy using GC nanocarriers also introduced for overcoming challenges of chemotherapeutics. Expert opinion: Based on the reviewed literature, physicochemical properties of GC nanocarriers will have a great potential to overcome challenges posed by chemotherapeutics.

Original languageEnglish
Pages (from-to)835-846
Number of pages12
JournalExpert Opinion on Drug Delivery
Volume16
Issue number8
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Neoplasms
Pharmaceutical Preparations
Expert Testimony
Antineoplastic Agents
glycol-chitosan
Peptides
Water
Therapeutics
Genes
Drug Liberation

Keywords

  • cancer therapy
  • chemotherapy
  • drug delivery
  • Glycol chitosan nanocarrier

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Tumor-targeting glycol chitosan nanocarriers : overcoming the challenges posed by chemotherapeutics. / Choi, Yongwhan; Lim, Seungho; Yoon, Hong Yeol; Kim, Byung Soo; Kwon, Ick Chan; Kim, Kwang Meyung.

In: Expert Opinion on Drug Delivery, Vol. 16, No. 8, 01.01.2019, p. 835-846.

Research output: Contribution to journalReview article

Choi, Yongwhan ; Lim, Seungho ; Yoon, Hong Yeol ; Kim, Byung Soo ; Kwon, Ick Chan ; Kim, Kwang Meyung. / Tumor-targeting glycol chitosan nanocarriers : overcoming the challenges posed by chemotherapeutics. In: Expert Opinion on Drug Delivery. 2019 ; Vol. 16, No. 8. pp. 835-846.
@article{7adbcc66ded946ba8091120f0522ae92,
title = "Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics",
abstract = "Introduction: In the past decade, the glycol chitosan nanocarriers (GCNCs) have been widely used for tumor-targeted delivery of anticancer agents such as chemo drugs, peptides, and genes due to their biocompatibility, biodegradability, and easy fabrication. In particular, GCNCs can effectively solubilize water-insoluble chemo drugs as well as improve the delivery efficiency of chemo drugs to the tumor, resulting in maximizing therapeutic efficacy and minimizing side effect. In this review, we introduce the various applications of GCNCs for cancer treatment and these GCNCs demonstrate the great potential in overcoming challenges of chemotherapeutics. Areas covered: Various designs of GC nanocarriers have been reviewed. The current state of GC nanocarriers for delivering chemotherapeutics with a focus on their physicochemical properties including solubilization of anti-cancer drugs, sustained release, and tumor-selectivity. Furthermore, state of the art in delivery and therapeutic strategy using GC nanocarriers also introduced for overcoming challenges of chemotherapeutics. Expert opinion: Based on the reviewed literature, physicochemical properties of GC nanocarriers will have a great potential to overcome challenges posed by chemotherapeutics.",
keywords = "cancer therapy, chemotherapy, drug delivery, Glycol chitosan nanocarrier",
author = "Yongwhan Choi and Seungho Lim and Yoon, {Hong Yeol} and Kim, {Byung Soo} and Kwon, {Ick Chan} and Kim, {Kwang Meyung}",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/17425247.2019.1648426",
language = "English",
volume = "16",
pages = "835--846",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Tumor-targeting glycol chitosan nanocarriers

T2 - overcoming the challenges posed by chemotherapeutics

AU - Choi, Yongwhan

AU - Lim, Seungho

AU - Yoon, Hong Yeol

AU - Kim, Byung Soo

AU - Kwon, Ick Chan

AU - Kim, Kwang Meyung

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: In the past decade, the glycol chitosan nanocarriers (GCNCs) have been widely used for tumor-targeted delivery of anticancer agents such as chemo drugs, peptides, and genes due to their biocompatibility, biodegradability, and easy fabrication. In particular, GCNCs can effectively solubilize water-insoluble chemo drugs as well as improve the delivery efficiency of chemo drugs to the tumor, resulting in maximizing therapeutic efficacy and minimizing side effect. In this review, we introduce the various applications of GCNCs for cancer treatment and these GCNCs demonstrate the great potential in overcoming challenges of chemotherapeutics. Areas covered: Various designs of GC nanocarriers have been reviewed. The current state of GC nanocarriers for delivering chemotherapeutics with a focus on their physicochemical properties including solubilization of anti-cancer drugs, sustained release, and tumor-selectivity. Furthermore, state of the art in delivery and therapeutic strategy using GC nanocarriers also introduced for overcoming challenges of chemotherapeutics. Expert opinion: Based on the reviewed literature, physicochemical properties of GC nanocarriers will have a great potential to overcome challenges posed by chemotherapeutics.

AB - Introduction: In the past decade, the glycol chitosan nanocarriers (GCNCs) have been widely used for tumor-targeted delivery of anticancer agents such as chemo drugs, peptides, and genes due to their biocompatibility, biodegradability, and easy fabrication. In particular, GCNCs can effectively solubilize water-insoluble chemo drugs as well as improve the delivery efficiency of chemo drugs to the tumor, resulting in maximizing therapeutic efficacy and minimizing side effect. In this review, we introduce the various applications of GCNCs for cancer treatment and these GCNCs demonstrate the great potential in overcoming challenges of chemotherapeutics. Areas covered: Various designs of GC nanocarriers have been reviewed. The current state of GC nanocarriers for delivering chemotherapeutics with a focus on their physicochemical properties including solubilization of anti-cancer drugs, sustained release, and tumor-selectivity. Furthermore, state of the art in delivery and therapeutic strategy using GC nanocarriers also introduced for overcoming challenges of chemotherapeutics. Expert opinion: Based on the reviewed literature, physicochemical properties of GC nanocarriers will have a great potential to overcome challenges posed by chemotherapeutics.

KW - cancer therapy

KW - chemotherapy

KW - drug delivery

KW - Glycol chitosan nanocarrier

UR - http://www.scopus.com/inward/record.url?scp=85070469456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070469456&partnerID=8YFLogxK

U2 - 10.1080/17425247.2019.1648426

DO - 10.1080/17425247.2019.1648426

M3 - Review article

C2 - 31343904

AN - SCOPUS:85070469456

VL - 16

SP - 835

EP - 846

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 8

ER -